$23.48 -0.99 (-4.05%)
7/2/2009 4:00 PM

Dendreon Corp (DNDN)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

Current Price $23.48 Mkt Cap $2.79B
Open $0.00 P/E Ratio 0.00
Prev. Close $24.47 Div. (Yield) N/A (N/A)
Daily Range $23.38 - $24.17 Volume 0
52-Wk Range $2.55 - $27.40 Avg. Daily Vol. 0

DNDN News and Articles

All stories about DNDN

Caps

How do you think DNDN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

1,093 Outperform
297 Underperform
 

All-Star Members

371 Outperform
102 Underperform
 

Wall Street

9 Outperform
4 Underperform
 

Top DNDN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

bhessel (95.37)
Submitted April 14, 2009

BUY Dendreon (DNDN)—potential cure for cancer (again)

Posted by intelledgement on Tue, 14 Apr 09

Yep, we are once again dipping into the Dendreon well. If you were not around in 2007, please read our original pitch for buying… More

5 Comments | Reply | Report this Post

JGus (99.07)
Submitted May 14, 2009

Bet the wrong way on this one. Here's a good lesson for all of you...when it comes to small drug companies, most will fail because the drugs they are developing fail and they run out of money. However, those that actually survive long enough to bring… More

4 Comments | Reply | Report this Post
DNDN VS S&P 500 (SPY)

Fools bullish on DNDN are also bullish on:

Fools bearish on DNDN are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about DNDN.

Recs

1
Member Avatar xserver (98.93) Submitted: 6/23/2009 12:57:16 AM : Underperform Start Price: $24.00 DNDN Score: +2.55

They don't even understand how diagnose prostate cancer, let alone treat it.

Report this Post 3 Comments | Reply | Permalink

Recs

1
Member Avatar SuitedAces (69.12) Submitted: 6/20/2009 2:24:49 AM : Outperform Start Price: $4.58 DNDN Score: +409.79

Future looks really good from here....FDA approval, Row partner , and always a chance a big Pharma steps in and buys them out and thats not even considering thier pipeline potential for new products (breast cancer ) already in the works. If you missed the initial runup it's not to late , theres lots of upward potential as one or all of the possibilities i mentioned materialize. I sold 1/3 of my position after the Bear Raid Fiasco to cover my costs once trading resumed ($26.25/share) I'll sell another 1/3 at $60 and keep the last 1/3 for the long haul. Rumors of a possible split this summer to, like i said lots of things yet to happen that will move this stock higher. GLTA !

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar Scientist007 (84.08) Submitted: 6/16/2009 3:10:37 AM : Underperform Start Price: $25.61 DNDN Score: +4.65

See week of April 30 through May 6, 2007....

That's my pitch, and before I ever enter this pick, I can almost say for sure that I'm one of a very few giving it a red thumb, even now after the huge run....

The Scientist

Report this Post 2 Comments | Reply | Permalink
View All 316 Pitches »

Leaderboard

Find the members with the highest scoring picks in DNDN.

Score Leader

stockgripes

stockgripes (97.19) Score: +858.36

Can't touch this ;)

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
chd1028 < 20 3/9/2009 Outperform NS $2.56 +817.19% +32.13% +785.06 1 Comment
feew3339 99.39 3/6/2009 Outperform NS $2.62 +796.15% +33.09% +763.06
Bucks1977 50.84 3/6/2009 4/3/2009 Outperform 3M $2.76 +750.72% +30.25% +720.47
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. i12Bravo 98.14 3/12/2009 6/1/2009 Outperform 1Y $2.82 +732.62% +23.67% +708.95
mojavemystic < 20 3/12/2009 Outperform 5Y $2.83 +729.71% +23.28% +706.43
Ranoff 96.43 3/11/2009 Outperform NS $2.90 +709.66% +23.03% +686.63 1 Comment
Gunsmoke2008 63.68 3/5/2009 Outperform NS $2.92 +704.11% +28.19% +675.92
tgga99 98.85 3/3/2009 Outperform 5Y $2.99 +685.28% +25.50% +659.78
westsider317 < 20 3/4/2009 Outperform 5Y $3.02 +677.48% +25.93% +651.56
Pooltableman17 < 20 3/2/2009 Outperform 3M $3.03 +674.92% +23.84% +651.08 1 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackCitigroup 87.14 6/10/2009 Outperform NS $26.07 -9.93% -5.94% -4.00
TrackDeutscheSec 85.14 6/5/2009 Outperform NS $26.75 -12.22% -5.98% -6.25
TrackMcAdamsWrig 34.17 5/8/2009 Underperform NS $19.29 +34.01% -1.51% -35.52 6/22/2009 @ $25.85
TrackNeedham 75.83 4/29/2009 Outperform NS $27.00 -13.04% +3.83% -16.86
TrackWachovia 75.72 4/29/2009 Outperform NS $27.00 -13.04% +3.83% -16.86
TrackBreanMurray 96.33 4/29/2009 Outperform NS $27.00 -13.04% +3.83% -16.86
TrackMerrimanCo < 20 4/22/2009 Outperform NS $20.57 +14.15% +6.55% +7.60
TrackLazardCapit 41.24 4/20/2009 Outperform NS $18.66 +25.83% +4.99% +20.84
TrackRodmanRen 81.15 4/14/2009 Outperform NS $17.37 +35.16% +6.02% +29.14
TrackZacks 75.50 4/14/2009 Outperform 3M $16.99 +38.20% +6.47% +31.73 1 Comment
TrackMerrimanCo < 20 10/16/2008 Underperform NS $4.95 +315.56% -7.69% -323.25 4/22/2009 @ $20.57
TrackJMP 29.30 7/12/2007 Underperform NS $7.88 +197.97% -41.06% -239.03
TrackBreanMurray 96.33 5/11/2007 Underperform NS $5.13 +250.88% -42.89% -293.77 4/14/2009 @ $18.00
TrackBofASec 95.34 5/10/2007 Underperform NS $5.75 +308.35% -40.42% -348.76
TrackUBS 86.07 5/8/2007 Underperform NS $17.14 +36.99% -40.35% -77.33
TrackJimCramer 64.82 5/7/2007 Underperform 3W $17.92 +31.03% -40.50% -71.53
TrackNextGen 82.20 5/3/2007 Outperform NS $18.13 +29.51% -40.13% +69.64
TrackJimCramer 64.82 4/5/2007 Outperform 3W $18.05 -0.72% +4.65% -5.37 5/8/2007 @ $17.92
TrackJMP 29.30 3/30/2007 Outperform NS $17.92 -62.95% +7.21% -70.15 5/24/2007 @ $6.64
TrackJimCramer 64.82 3/28/2007 Underperform 3W $5.22 +245.79% +1.71% -244.08 4/6/2007 @ $18.05

Featured Broker Partners